Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Regulus Therapeutics Shares Outstanding 2011-2020 | RGLS

Regulus Therapeutics shares outstanding from 2011 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Regulus Therapeutics Annual Shares Outstanding
(Millions of Shares)
2019 17
2018 9
2017 6
2016 4
2015 4
2014 4
2013 3
2012 1
2011 0
2010
Regulus Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2020-03-31 24
2019-12-31 17
2019-09-30 21
2019-06-30 17
2019-03-31 10
2018-12-31 9
2018-09-30 9
2018-06-30 9
2018-03-31 9
2017-12-31 6
2017-09-30 8
2017-06-30 4
2017-03-31 4
2016-12-31 4
2016-09-30 4
2016-06-30 4
2016-03-31 4
2015-12-31 4
2015-09-30 4
2015-06-30 4
2015-03-31 4
2014-12-31 4
2014-09-30 4
2014-06-30 4
2014-03-31 4
2013-12-31 3
2013-09-30 3
2013-06-30 3
2013-03-31 3
2012-12-31 1
2012-09-30 0
2012-06-30 0
2012-03-31 0
2011-12-31
2011-09-30 0
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.018B $0.007B
Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs, called microRNA therapeutics. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulus Therapeutics Inc. is based in La Jolla, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.751B 37.31
Takeda Pharmaceutical (TAK) Japan $55.142B 9.66
Astellas Pharma (ALPMY) Japan $29.910B 15.16
Eisai (ESALY) Japan $23.461B 20.34
UCB SA (UCBJF) Belgium $23.292B 0.00
Merck (MKGAF) Germany $16.149B 21.18
Grifols, S.A (GRFS) Spain $12.857B 15.98
Neurocrine Biosciences (NBIX) United States $11.883B 54.92
Catalent (CTLT) United States $11.421B 44.15
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.553B 45.47
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $6.978B 31.27
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.021B 9.64
United Therapeutics (UTHR) United States $5.220B 9.89
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.502B 491.56
Nektar Therapeutics (NKTR) United States $4.297B 0.00
Evotec AG (EVTCY) Germany $4.181B 112.67
Hypermarcas (HYPMY) Brazil $3.762B 11.44
FibroGen (FGEN) United States $3.713B 0.00
ChemoCentryx (CCXI) United States $3.637B 0.00
PTC Therapeutics (PTCT) United States $3.602B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.561B 10.53
Pacira BioSciences (PCRX) United States $2.282B 46.70
Cronos Group (CRON) Canada $2.187B 62.70
Sage Therapeutics (SAGE) United States $2.178B 0.00
Corcept Therapeutics (CORT) United States $1.901B 18.85
Xencor (XNCR) United States $1.857B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.722B 0.00
USANA Health Sciences (USNA) United States $1.708B 17.52
Akebia Therapeutics (AKBA) United States $1.697B 0.00
Indivior (INVVY) United States $1.638B 20.33
Ironwood Pharmaceuticals (IRWD) United States $1.620B 12.40
Zogenix (ZGNX) United States $1.526B 0.00
Esperion Therapeutics (ESPR) United States $1.409B 0.00
Karyopharm Therapeutics (KPTI) United States $1.396B 0.00
Heron Therapeutics (HRTX) United States $1.361B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.359B 14.65
Theravance Biopharma (TBPH) Cayman Islands $1.302B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.103B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.009B 45.05
Tilray (TLRY) Canada $0.961B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.954B 0.00
ImmunoGen (IMGN) United States $0.841B 0.00
Endo (ENDP) Ireland $0.832B 1.29
Molecular Templates (MTEM) United States $0.659B 0.00
VAXART, INC (VXRT) United States $0.658B 0.00
Radius Health (RDUS) United States $0.652B 0.00
Ardelyx (ARDX) United States $0.623B 0.00
Aerie Pharmaceuticals (AERI) United States $0.619B 0.00
Trillium Therapeutics (TRIL) Canada $0.608B 0.00
Collegium Pharmaceutical (COLL) United States $0.586B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.582B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.566B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.519B 12.55
BioSpecifics Technologies Corp (BSTC) United States $0.490B 19.11
Innate Pharma SA (IPHYF) France $0.476B 0.00
Flexion Therapeutics (FLXN) United States $0.475B 0.00
Siga Technologies (SIGA) United States $0.470B 0.00
DURECT (DRRX) United States $0.425B 0.00
TherapeuticsMD (TXMD) United States $0.416B 0.00
Harpoon Therapeutics (HARP) United States $0.414B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.402B 0.00
Ocular Therapeutix (OCUL) United States $0.401B 0.00
Organogenesis Holdings (ORGO) United States $0.380B 0.00
Calithera Biosciences (CALA) United States $0.373B 0.00
MEI Pharma (MEIP) United States $0.364B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.320B 0.00
Concert Pharmaceuticals (CNCE) United States $0.296B 0.00
PROFOUND MEDICL (PROF) Canada $0.292B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.289B 0.00
Lannett Co Inc (LCI) United States $0.268B 5.88
Oasmia Pharmaceutical AB (OASMY) Sweden $0.249B 0.00
Redhill Biopharma (RDHL) Israel $0.248B 0.00
CASI Pharmaceuticals (CASI) United States $0.229B 0.00
Taiwan Liposome (TLC) Taiwan $0.220B 0.00
Jounce Therapeutics (JNCE) United States $0.215B 5.14
KalVista Pharmaceuticals (KALV) United States $0.212B 0.00
OptiNose (OPTN) United States $0.208B 0.00
Rafael Holdings (RFL) United States $0.208B 0.00
IMV INC (IMV) Canada $0.188B 0.00
Nivalis Therapeutics (ALPN) United States $0.181B 0.00
Nature's Sunshine Products (NATR) United States $0.179B 23.59
Altimmune (ALT) United States $0.174B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.151B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.125B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.124B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
CTI BioPharma (CTIC) United States $0.114B 0.00
Otonomy (OTIC) United States $0.110B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.107B 0.00
Recro Pharma (REPH) United States $0.102B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.101B 0.00
MediWound (MDWD) Israel $0.100B 0.00
Onconova Therapeutics (ONTX) United States $0.099B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.099B 0.00
Xeris Pharmaceuticals (XERS) United States $0.098B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.091B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.091B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
Sundial Growers (SNDL) Canada $0.083B 0.00
Biomerica (BMRA) United States $0.080B 0.00
Heat Biologics (HTBX) United States $0.076B 0.00
Aclaris Therapeutics (ACRS) United States $0.074B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.066B 0.00
Lipocine (LPCN) United States $0.065B 0.00
CV Sciences (CVSI) United States $0.059B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 30.09
Infinity Pharmaceuticals (INFI) United States $0.050B 0.00
PolarityTE (PTE) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
IsoRay (ISR) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.040B 0.00
Novan (NOVN) United States $0.040B 0.00
GTx (ONCT) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.039B 7.40
Opiant Pharmaceuticals (OPNT) United States $0.039B 83.18
Adamis Pharmaceuticals (ADMP) United States $0.038B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.034B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.027B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.022B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Can-Fite Biopharma (CANF) Israel $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.016B 0.00
Shineco (TYHT) China $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 32.71
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Vical (BBI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00